Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 11,174 shares at $17.03 ($190K) on 2025-08-19, disclosed to the SEC on 2025-08-20.
Scheduled sale ($190k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.03 | 5,587 | $95K | 50.0% |
| 2 | $17.03 | 5,587 | $95K | 50.0% |
| Total | $17.03 avg | 11,174 | $190K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |